patientMpower attended the International Congress on Lung Transplantation. It brought together a fantastic range of pulmonologists, nurses, scientists and other professionals from all over the world working to improve outcomes in Lung Transplantation. The topics covered were many and varied, so here we’ve condensed a few takeaways for people considering a lung transplant.
This week I had the opportunity to attend the Lung Health Experience hosted by the American College of Chest Physicians (CHEST) in Chicago. This annual event helps spread awareness of asthma, COPD, lung cancer, pulmonary fibrosis and other lung health initiatives.
patientMpower will be exhibiting at ATS 2018 and we would like to invite you to come and visit us to learn more about our specialist remote patient tracking platforms for Pulmonary Fibrosis and Lung Transplant.
Whether you have only been recently diagnosed with pulmonary fibrosis, or have been diagnosed for a while and are starting to experience new symptoms or have recently started new treatments, it can sometimes feel that pulmonary fibrosis is overwhelming.
patientMpower for pulmonary fibrosis and lung transplant enables you to keep track of everything relating to your lung health, empowering you to get the best possible outcomes from your treatment and care. Our free app connects to devices you can use at home to track spirometry, pulse oximetry, medication reminders, air quality updates and step counter recording.
Three Lakes Partners, a venture philanthropy committed to ending Idiopathic Pulmonary Fibrosis (IPF), named Advanced Interactive Response Systems (AIRS), Owlstone Medical and patientMpower the winners of its $1,000,000 IPF Catalyst Challenge last night during a live finalist pitch event at MATTER’s Chicago headquarters. Level Ex was honored with the event’s Audience Choice Award.
patientMpower presented at the Artificial Intelligence Health2.0 Dublin chapter meetup hosted in January by Google and Verily. Eamonn Costello outlined the Machine Learning process patientMpower is employing in ‘cleaning’ and ‘training’ a real world spirometry data set. These data are contained within patientMpower’s “digital biobankTM“, which contains over 3 million Idiopathic Pulmonary Fibrosis (IPF) data points including thousands of Forced Vital Capacity (FVC) data points.
patientMpower attended the annual International Consortium for Health Outcome Measures (ICHOM) conferece in London recently, where thought leaders from around the world came together to discuss how to measure the outcomes that matter to patients and the path towards value based healthcare.